CD36 and posterior cortical atrophy: In our current study, we also show an upregulation of CD36 at SARIFAs in pT3a PCa, which is promising, as the efficacy of monoclonal antibodies against CD36 in the specific context of pT3a PCas has already been demonstrated by deploying patient-derived xenografts [17].